mJX-594, a targeted GM-CSF-armed vaccinia virus, remodelled the murine TME, driving T-cell tumour infiltration and upregulation of immune-related gene signatures such as DC maturation and type-1 IFN signalling [99]. This evidence concerns the gene CSF2 and neoplasm.